CoChat

Assessment and treatment of thyroid disorders in pregnancy and the postpartum period

Open access
Lee, Sun Y., Pearce, Elizabeth N. · 2022 · Nature Reviews Endocrinology
Cited by 206

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Abstract

Thyroid disorders are prevalent in pregnant women. Furthermore, thyroid hormone has a critical role in fetal development and thyroid dysfunction can adversely affect obstetric outcomes. Thus, the appropriate management of hyperthyroidism, most commonly caused by Graves disease, and hypothyroidism, which in iodine sufficient regions is most commonly caused by Hashimoto thyroiditis, in pregnancy is important for the health of both pregnant women and their offspring. Gestational transient thyrotoxicosis can also occur during pregnancy and should be differentiated from Graves disease. Effects of thyroid autoimmunity and subclinical hypothyroidism in pregnancy remain controversial. Iodine deficiency is the leading cause of hypothyroidism worldwide. Despite global efforts to eradicate iodine deficiency disorders, pregnant women remain at risk of iodine deficiency due to increased iodine requirements during gestation. The incidence of thyroid cancer is increasing worldwide, including in young adults. As such, the diagnosis of thyroid nodules or thyroid cancer during pregnancy is becoming more frequent. The evaluation and management of thyroid nodules and thyroid cancer in pregnancy pose a particular challenge. Postpartum thyroiditis can occur up to 1 year after delivery and must be differentiated from other forms of thyroid dysfunction, as treatment differs. This Review provides current evidence and recommendations for the evaluation and management of thyroid disorders in pregnancy and in the postpartum period. Thyroid hormone is important during pregnancy, as it facilitates appropriate fetal development. Furthermore, thyroid dysfunction during pregnancy can negatively affect obstetric outcomes and maternal health. This Review discusses the evaluation and management of thyroid disorders in pregnancy and in the postpartum period. Serum levels of thyroid stimulating hormone might be lower in pregnant women during early gestation than levels outside the pregnancy setting, due to increased production of thyroid hormone and stimulation from high levels of human chorionic gonadotropin. Levothyroxine treatment for maternal subclinical hypothyroidism in pregnancy remains controversial because currently available studies have not shown a clear benefit of treatment on obstetric or child neurodevelopmental outcomes. Treatment of Graves disease in pregnancy requires careful consideration of the adverse effects of uncontrolled hyperthyroidism, antithyroid drugs and overtreatment of hyperthyroidism on pregnancy outcomes. Women who are planning to be pregnant, are pregnant or are breastfeeding should take a daily oral supplement containing 150 µg of iodine to prevent adverse effects of iodine deficiency. Treatment of differentiated thyroid cancer diagnosed in pregnancy can be safely deferred until after pregnancy with close monitoring for any tumour size increase or spread during pregnancy. Postpartum thyroiditis is a destructive thyroiditis that typically presents with thyrotoxicosis followed by transient hypothyroidism up to the first 12 months after childbirth.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41574-021-00604-z

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 32 references

Cited by

See all 206

Metadata

Authors
Lee, S. Y., & Pearce, E. N.
Venue
Nature Reviews Endocrinology
Published
2022-01-04
Volume
18
Issue
3
Pages
158-171
ISSN
  • 1759-5029 (ISSN-L)
  • 1759-5037
OpenAlex
W4205522425
Cited by
206
References
32
FWCI
8.59
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Assessment and treatment of thyroid disorders in pregnancy and the postpartum period. https://app.cochat.ai/papers/10.1038/s41574-021-00604-z
The paper
Lee, S. Y., & Pearce, E. N. (2022). Assessment and treatment of thyroid disorders in pregnancy and the postpartum period. Nature Reviews Endocrinology. https://doi.org/10.1038/s41574-021-00604-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.